Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Unraveling a contributing factor in neurodegenerative disease: Investigating the molecular links between mistranslation and neurodegeneration.

FY 2019-20

Summary
" Protein formation and how it folds into its final structure is critical for its normal function. Incorrect folding (misfolding) of proteins and their build up in tissue is characteristic of cancer, metabolic, and neurodegenerative diseases, including Alzheimer's disease (AD). A protein is made in a sequence of processes known as the ""Central Dogma"": DNA is transcribed into messenger RNA, which is translated into an amino acid (AA) chain that form the protein. Although vital, errors occur in translation, where an incorrect AA is added in the chain (mistranslation). As the sequence of AAs is critical for how a protein folds, and also its function, mistranslation may lead to misfolding and disease. One of the characteristics of AD, as well as other neurodegenerative diseases, is the misfolding and subsequent aggregation (clumping) of the protein tau. Much research has investigated tau aggregation, but the primary trigger is still unknown. The purpose of our research is to investigate whether mistranslation of the tau protein triggers its misfolding and aggregation. We will use human neuron cell models, which will produce tau, and a mutated Methionine aminoacyl-tRNA synthetase enzyme which is prone to cause mistranslation by incorrectly adding the AA Methionine into protein chains. Further, it has been shown that oxidative stress, which has high levels in AD, causes a similar alteration of this enzyme. If oxidative stress promotes mistranslation of tau proteins, we will see its aggregation in our cells. We also aim to use mass spectrometry and novel bioinformatic tools to investigate which AAs in tau are vulnerable to mistranslation. This research is vital as it contributes to the collective effort to find the cause of tau aggregation in neurodegenerative diseases. "
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428722
Name
Britton Angelle P
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Unraveling a contributing factor in neurodegenerative disease: Investigating the molecular links between mistranslation and neurodegeneration.
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Aminoacyl-Trna Synthetases; Bioinformatics; Mass Spectrometry; Mistranslation; Neurodegeneration; Neuron Cell Models; Oxidative Stress; Protein Aggregation; Tau Protein
Abstract
" Protein formation and how it folds into its final structure is critical for its normal function. Incorrect folding (misfolding) of proteins and their build up in tissue is characteristic of cancer, metabolic, and neurodegenerative diseases, including Alzheimer's disease (AD). A protein is made in a sequence of processes known as the ""Central Dogma"": DNA is transcribed into messenger RNA, which is translated into an amino acid (AA) chain that form the protein. Although vital, errors occur in translation, where an incorrect AA is added in the chain (mistranslation). As the sequence of AAs is critical for how a protein folds, and also its function, mistranslation may lead to misfolding and disease. One of the characteristics of AD, as well as other neurodegenerative diseases, is the misfolding and subsequent aggregation (clumping) of the protein tau. Much research has investigated tau aggregation, but the primary trigger is still unknown. The purpose of our research is to investigate whether <em>mistranslation of the tau protein</em> triggers its misfolding and aggregation. We will use human neuron cell models, which will produce tau, and a mutated Methionine aminoacyl-tRNA synthetase enzyme which is prone to cause mistranslation by incorrectly adding the AA Methionine into protein chains. Further, it has been shown that oxidative stress, which has high levels in AD, causes a similar alteration of this enzyme. If oxidative stress promotes mistranslation of tau proteins, we will see its aggregation in our cells. We also aim to use mass spectrometry and novel bioinformatic tools to investigate which AAs in tau are vulnerable to mistranslation. This research is vital as it contributes to the collective effort to find the cause of tau aggregation in neurodegenerative diseases. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Britton, Angelle P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~